Report Feature
The future of the global bioprocess technology market looks promising with opportunities in antibiotic, recombinant protein, monoclonal antibody, and biosimilar applications. The global bioprocess technology market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing production of bio-pharmaceuticals, like recombinant protein, vaccines, and rising investments in research and development by biotechnology and pharmaceutical companies.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global bioprocess technology market report, please download the report brochure.
In this market, recombinant protein is the largest application segment of bioprocess technology. Growth in various segments of the bioprocess technology market are given below:
The study includes trends and forecast for the global bioprocess technology market by product, application, end use, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Instruments
- Bioprocess Analyzers
- Blood Gas Analyzers
- Osmometers, Cell Counter Systems
- Bioreactors
- Incubators
- Consumables & Accessories
- Culture Media
- Reagents
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Antibiotics
- Recombinant Protein
- Monoclonal Antibodies
- Biosimilars
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Academic Research Institutes
- Food and Feed Industry
- Contract Research Organizations
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the bioprocess technology companies profiled in this report include Philips Healthcare, Abbott Laboratories, Thermo Fisher Scientific, Alere, B&D, Merck Millipore, Danaher, Lonza, Sartorius Stedim Biotech, and Corning.
Within this market, recombinant protein will remain the largest application segment over the forecast period due to increasing prevalence of chronic and infectious diseases as recombinant therapeutic protein provides important therapies for such diseases.
North America will remain the largest region over the forecast period due to rising prevalence of chronic diseases, developed healthcare infrastructure, and presence of major players in the region.
|
Features of the Global Bioprocess Technology Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global bioprocess technology market by product (instruments [bioprocess analyzers, blood gas analyzers, osmometers, cell counter systems, bioreactors, and incubators] and consumables & accessories [culture media and reagents]), application (antibiotics, recombinant protein, monoclonal antibodies, and biosimilars), end use (biopharmaceutical companies, contract manufacturing organizations, academic research institutes, food & feed industry, and contract research organizations), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global bioprocess technology market? Q.5 What are the business risks and threats to the global bioprocess technology market? Q.6 What are the emerging trends in this bioprocess technology market and the reasons behind them? Q.7 What are some changing demands of customers in this bioprocess technology market? Q.8 What are the new developments in this bioprocess technology market? Which companies are leading these developments? Q.9 Who are the major players in this bioprocess technology market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this bioprocess technology market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global bioprocess technology market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents)), Application (Antibiotics, Recombinant Protein, Monoclonal Antibodies, and Biosimilars), and End use (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institutes, Food & Feed Industry, and Contract Research Organizations) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Bioprocess Technology Market
4.1 Global Bioprocess Technology Market by Region
4.2.1 Market by Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents)
4.2.2 Market by Application: Antibiotics, Recombinant Protein, Monoclonal Antibodies, and Biosimilars
4.2.3 Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institutes, Food and Feed Industry, and Contract Research Organizations
4.2.4 The United States Bioprocess Technology Market
4.2.5 The Canadian Bioprocess Technology Market
4.2.6 The Mexican Bioprocess Technology Market
4.3.1 Market by Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents)
4.3.2 Market by Application: Antibiotics, Recombinant Protein, Monoclonal Antibodies, and Biosimilars
4.3.3 Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institutes, Food and Feed Industry, and Contract Research Organizations
4.3.4 The Bioprocess Technology Market of United Kingdom
4.3.5 The German Bioprocess Technology Market
4.3.6 The French Bioprocess Technology Market
4.4.1 Market by Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents)
4.4.2 Market by Application: Antibiotics, Recombinant Protein, Monoclonal Antibodies, and Biosimilars
4.4.3 Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institutes, Food and Feed Industry, and Contract Research Organizations
4.4.4 The Chinese Bioprocess Technology Market
4.4.5 The Indian Bioprocess Technology Market
4.4.6 The Japanese Bioprocess Technology Market
4.5.1 Market by Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents)
4.5.2 Market by Application: Antibiotics, Recombinant Protein, Monoclonal Antibodies, and Biosimilars
4.5.3 Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institutes, Food and Feed Industry, and Contract Research Organizations
4.5.4 Brazilian Bioprocess Technology Market
7.1.1 Growth Opportunities for the Global Bioprocess Technology Market by Product
7.1.2 Growth Opportunities for the Global Bioprocess Technology Market by Application
7.1.3 Growth Opportunities for the Global Bioprocess Technology Market by End Use
7.1.4 Growth Opportunities for the Global Bioprocess Technology Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
